Wednesday, July 21, 2021

JUBLINGREA | Potential Outperformer | Stock Analysis & Price Outlook

   

investment , finvestonline.com

Jubilant Ingrevia

CMP 587


➽  Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. 


FCL| Stock Analysis & Price Outlook 



➽ Key Stat

Promoters increasing shareholding QoQ

Growth in Net Profit with increasing Profit Margin (QoQ)

Company with Zero Promoter Pledge

Near 52 Week High

Bullish Momentum - Above Short, Medium and Long Term Moving Averages



➽ Recent Shareholdings

Promoters have increased holdings from 50.68% to 50.92% in Jun 2021 qtr.

Mutual Funds have decreased holdings from 0.82% to 0.77% in Jun 2021 qtr

Number of MF schemes decreased from 5 to 4 in Jun 2021 qtr

FII/FPI have decreased holdings from 24.28% to 18.7% in Jun 2021 qtr

Number of FII/FPI investors decreased from 174 to 120 in Jun 2021 qtr

Institutional Investors have decreased holdings from 25.58% to 20.14% in Jun 2021 qtr


KIRLOSENG | Stock Analysis & Price Outlook


 Technical & Price Levels

Moving Averages Bullish

Technical Indicators Bullish

Moving Averages Crossovers Bullish

JUBLINGREA  share price , finvestonline.com

After long consolidation stock given an important breakout with good volume.

Long position can be made for the potential upside level of 628 - 674 in short to  mid term. 




Thanks for your Precious Time.


Finvest Online
Telegram  :  https://t.me/finvestonlineChat






Disclaimer- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader,user and company that are mention on this website.  Please remember that this is a blog, and you do not need to agree with anything I write.We are not SEBI registered financial advisor or analyst.


No comments:

Post a Comment